SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-128252
Filing Date
2022-12-19
Accepted
2022-12-19 16:21:31
Documents
3
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2232974d1_sc13g.htm SC 13G 65627
2 EXHIBIT 1 tm2232974d1_ex99-1.htm EX-99.1 36108
3 EXHIBIT 2 tm2232974d1_ex99-2.htm EX-99.2 6414
  Complete submission text file 0001104659-22-128252.txt   109617
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13G

Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Subject) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92728 | Film No.: 221471368
SIC: 2834 Pharmaceutical Preparations